Institute for Ethics and Emerging Technologies


The IEET is a 501(c)3 non-profit, tax-exempt organization registered in the State of Connecticut in the United States. Please give as you are able, and help support our work for a brighter future.


Search the IEET
Subscribe and Contribute to:


Technoprogressive? BioConservative? Huh?
Quick overview of biopolitical points of view




whats new at ieet

Color and Sound Perception Explained

Transhumanisme : Comment sortir de la « Vallée de l’étrange » ? 2/2

On tragedy, ethics and the human condition.

Zoos Enrich Our Lives but Cost Animals Their Dignity

China May Be the Reason that Speech Recognition Takes Off

The Psychology of Solitude: Being Alone Can Maximize Productivity


ieet books

Philosophical Ethics: Theory and Practice
Author
John G Messerly


comments

instamatic on 'WHAT MORAL ENHANCEMENT?' (Jun 22, 2016)

Giulio Prisco on 'Paradiso and Inferno in Robin Hanson's 'The Age of EM'' (Jun 22, 2016)

Giulio Prisco on 'Paradiso and Inferno in Robin Hanson's 'The Age of EM'' (Jun 22, 2016)

Pastor_Alex on 'WHAT MORAL ENHANCEMENT?' (Jun 20, 2016)

Lincoln Cannon on 'The Semi-Orthogonality Thesis - examining Nick Bostrom’s ideas on intelligent purpose' (Jun 18, 2016)

rms on 'Does Self-Tracking Promote Autonomy? An Initial Argument' (Jun 17, 2016)

instamatic on 'History Lesson: Trump's Rise Might Signal the Collapse of the Republican Party' (Jun 15, 2016)







Subscribe to IEET News Lists

Daily News Feed

Longevity Dividend List

Catastrophic Risks List

Biopolitics of Popular Culture List

Technoprogressive List

Trans-Spirit List



JET

Enframing the Flesh: Heidegger, Transhumanism, and the Body as “Standing Reserve”

Moral Enhancement and Political Realism

Intelligent Technologies and Lost Life

Hottest Articles of the Last Month


Will Transhumanism Change Racism in the Future?
Jun 2, 2016
(5420) Hits
(0) Comments

Dubai Is Building the World’s Largest Concentrated Solar Power Plant
Jun 20, 2016
(3782) Hits
(0) Comments

A snapshot on the fight against death
Jun 1, 2016
(3373) Hits
(4) Comments

New Evidence Suggests a Fifth Fundamental Force of Nature
Jun 13, 2016
(3274) Hits
(0) Comments



IEET > Life > Innovation > Health > Vision > Bioculture > Technoprogressivism > Directors > George Dvorsky

Print Email permalink (0) Comments (6241) Hits •  subscribe Share on facebook Stumble This submit to reddit submit to digg


First Successful Gene-Editing in Live Mammals Brings Us Closer to Human Treatments


George Dvorsky
By George Dvorsky
Gizmodo

Posted: Jan 22, 2016

For the first time ever, scientists have used the CRISPR gene-editing tool to successfully treat a genetic muscle disorder in a living adult mammal. It’s a promising medical breakthrough that could soon lead to human therapies.

Scientists have struggled to treat Duchenne muscular dystrophy for decades. To date, their efforts have been focused on treating cultured cells in petri dishes, or in trying to get CRISPR/cas9, a powerful DNA cut-and-paste tool, to deliver the repaired copy of the defective genes effectively and safely. Now, using a specially modified virus, researchers from Duke University have confirmed a promising solution using live mouse models. The team’s study appears in the latest edition of Science.

Duchenne muscular dystrophy is a muscle-wasting disease that affects one in 5,000 newborn males. The genetic glitch is on the X chromosome, so girls with two X chromosomes tend to have at least one functioning copy of the gene. Symptoms typically appear between the ages of 3 and 5, after which the disorder progresses quickly. Most boys are unable to walk by the time they’re 12, and they eventually need a respirator to breathe. Life expectancy is between 20 to 30 years.

The genetic disorder is caused by the absence of dystrophin, a critically important long protein chain that maintains the integrity of muscles. Dystrophin is coded by a gene containing nearly 80 protein-coding regions called exons. If even a single exon is badly mutated, the chain won’t get built. And without dystrophin, muscles slowly deteriorate. 

The restored production of dystrophin (light green) in the muscle cells of mice. Credit: C. E. Nelson et al., 2015

The Duke researchers, led by geneticist Chris Nelson, used CRISPR/cas9 to remove the problematic DNA that was preventing the cells from producing dystrophin. 

CRISPR, a tool that emerged just three years ago, allows scientists to edit genomes with incredible precision and flexibility. Like a person trying to solve a jigsaw puzzle, the system uses synthetic DNA known as CRISPRs to scan a genome in search of the right spot. A protein called cas9 acts as a pair of scissors to cut through the DNA.

To deliver these genetic alterations, the Duke researchers used a type of non-pathogenic virus. “A major hurdle for gene editing is delivery. We know what genes need to be fixed for certain diseases, but getting the gene editing tools where they need to go is a huge challenge,” said Nelson in a release. “The best way we have to do it right now is to take advantage of viruses, because they have spent billions of years evolving to figure out how to get their own viral genes into cells.”

For the study, the researchers worked with genetically modified mice that had the debilitating mutation on one of the exons of the dystrophin gene. The scientists programmed the new CRISPR/cas9 system to weed out the dysfunctional exon, leaving the body’s natural repair system to stitch the remaining gene back together. The result was a shortened, but functional, version of the gene. 

In order to reach every muscle, the virus was injected into the bloodstream of the mice. Results showed measurable corrections of muscles throughout the body, including the heart—a particularly important result, considering that heart failure is major cause of death among Duchenne patients.

However, the mice that received the therapy did not do as well as normal mice on muscle tests, so it’s not a cure. That said, the researchers believe there’s plenty of room for improvement, and that upwards of 80-percent of people with DMD could benefit from having a faulty exon removed. 

“There is still a significant amount of work to do to translate this to a human therapy and demonstrate safety,” said Duke researcher Charles A. Gersbach. “But these results coming from our first experiments are very exciting. From here, we’ll be optimizing the delivery system, evaluating the approach in more severe models of DMD, and assessing efficiency and safety in larger animals with the eventual goal of getting into clinical trials.”

Two other teams—all working independently from one another—achieved similar results in their research. These studies were conducted by Eric Olson at the University of Texas Southwestern Medical Center and Amy Wager at Harvard University.

Unlike efforts to modify the germline of embryos, this particular approach can be applied to a living being. This means the genetic changes can be introduced later in life, and they aren’t heritable.

“Recent discussion about using CRISPR to correct genetic mutations in human embryos has rightfully generated considerable concern regarding the ethical implications of such an approach,” said Gersbach “But using CRISPR to correct genetic mutations in the affected tissues of sick patients is not under debate. These studies show a path where that’s possible, but there’s still a considerable amount of work to do.”

[Duke University, New York Times, Science AAAS]


George P. Dvorsky serves as Chair of the IEET Board of Directors and also heads our Rights of Non-Human Persons program. He is a Canadian futurist, science writer, and bioethicist. He is a contributing editor at io9 — where he writes about science, culture, and futurism — and producer of the Sentient Developments blog and podcast. He served for two terms at Humanity+ (formerly the World Transhumanist Association). George produces Sentient Developments blog and podcast.
Print Email permalink (0) Comments (6242) Hits •  subscribe Share on facebook Stumble This submit to reddit submit to digg


COMMENTS


YOUR COMMENT (IEET's comment policy)

Login or Register to post a comment.

Next entry: Transhuman Debate in SF East Bay, co-sponsored by IEET

Previous entry: Is Resistance Futile? Are we already Borg?

HOME | ABOUT | FELLOWS | STAFF | EVENTS | SUPPORT  | CONTACT US
SECURING THE FUTURE | LONGER HEALTHIER LIFE | RIGHTS OF THE PERSON | ENVISIONING THE FUTURE
CYBORG BUDDHA PROJECT | AFRICAN FUTURES PROJECT | JOURNAL OF EVOLUTION AND TECHNOLOGY

RSSIEET Blog | email list | newsletter |
The IEET is a 501(c)3 non-profit, tax-exempt organization registered in the State of Connecticut in the United States.

East Coast Contact: Executive Director, Dr. James J. Hughes,
56 Daleville School Rd., Willington CT 06279 USA 
Email: director @ ieet.org     phone: 860-428-1837

West Coast Contact: Managing Director, Hank Pellissier
425 Moraga Avenue, Piedmont, CA 94611
Email: hank @ ieet.org